[Kidney transplantation in high-risk patients].
Immunosuppression with Cyclosporine A in kidney transplantation, triple therapy (CyA + Imuran + corticosteroids) and plasmapheresis before and after kidney transplantation in high risk recipients (positive cytotoxic antibody, MLC at the level of non related persons), also in high risk patients (juvenile diabetes, patients over 50 years old). In 1988 we had done in our Centre, kidney transplantation in 52.8% (28: 53) in high and increased risk patients. Triple therapy with plasmapheresis before and after kidney transplantation (if the level of cytotoxic antibodies is over 15%) allows successful kidney transplantation in high risk kidney recipients. Patients with juvenile diabetes are also available kidney recipients with therapy and permanent regulation of blood sugar. The patients of the age group between 50-60 years should be considered as suitable for kidney transplantation.
Petronić
V
V
Borić
Z
Z
Marković
V
V
Krasojević-Kostić
I
I
Blagojević
R
R
Dujić
A
A
Stolić
I
I
Lezajić
V
V
Stojković
D
D
Lazić
M
M
D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000379:methods; D012307:Risk Factors
D007166:Immunosuppressive Agents
Transplantacija bubrega u bolesnika sa visokim rizikom.